Lilly’s GLP-1 pill beats older Novo diabetes drug in head-to-head trial

Please subscribe to IBJ to decode this article.

artelana. io snrh obdnv plNi a-inlhb togtre lociw ttSic ’rd e itoteor elrsum ewx- ftlrkAth a Poslaeeo saoseer ydfofiani/ oe ontn olntNdnamdeahssn mserd de .,tLl oatlsh d i eee ahppnetiadlvhridtovgthEeCmobi piol idr roato

bh%L tditfrc h..ndiuhi kdeocn og 5i nrtod s oliudd etiRs —wdl.nyooo5lofeP itf’yno Lodl Nasoepsrdtgy iep 8t usd f 2desglru1roeehinoiael nglt olav o u,obyiyelNto’yslgh8ur t% trlas2Td .stebu5s gnw c,W nt t— iwo iu hlhn luvsp l v reged%e’oaiie r—toidbo ilv1fwrlteny. gdaoirltea e39ihs .hnlmnshohr eaeso—obgs2t% aeoao pawo sspl enrps w oh1i—o1 e,domrpsg re

7diWenshemspauyyeed0 y Lyeil.as5rd arldw .b%

redetsanpbtreprrh g nioeetiehac otyuf eelontp gden le otlnilp waEtot oaetnawsia iadi is krhrt apn siie ofmerodshttf eWiodeif sbtshe hohnlnsnt astgt ealsAooyrw sy.tn VlaS iaiat enl sauetLedehiikedfuo ly D

t vuetp,igoc e el hpldur uf , . whedrn’t oL earoglNac nhslremsxi ta sel af-s sdrdiefe nvxTte ie1 paGetpmpednoeatoaip vehbttt ,opvhvetes tada be rh coeeiphumPhtcioolsii-n teeeeltdir u

e et,cepbc.uo ioithllbaugrpalehttya c dcltd syl tliee sniLtet ede ks,g bmamatousnlettaoewvtitacbyoteiei t iaftaa neemr omnleekwur aDp tee o sh es gd ae t l sso pcl cig et yito iaet.eddeentbldek s kocp’so ls ut ilsosoiryiafnmea aiteaq tarr snep smerlherhm e

Bpw Dsyt afitibrVenv letro fTinen o fhfweielbp oeht to ,tnic’nse to tmanecmeweseptrai stvi oescnee lpy eStear bu“n’rhtou iiattecbsseian ermdno e vasvS.n na,ekpwieir” t es.ia aeselrofOiofrutlkrdcgio siyr g vgiemiyrpibhioeihem odls owiacmo ysolhhb”udo dr hbpWdco’oCghr l “ tna l ea nnam nw prdcscif sk eaullbecvoe lsnaeneatlnnyn tv ei I i lL

tkfoscapech sctsh ieyhna srie oklhyointr lrf0ooe ntoedtNhhtecohiniehropoe i mnocesonnr bvodva eetcostarol htm mletb yatatec .aBertea d eoBrhnte,er dt te oaces ctoieoc w i oea e y g o $ebyionie eghc gelei.dsuebitn gp,nlalava1i em vk bntfer hleebd gLr k it j hesalp clcllhlfI nbei hi,tet nmtae0d

s lsoee doeest.dl,ocyra tedtdhiriimlpm l w mwnassellwtlbsoe rt 1ln yieslaaen Ii n ened ,dhaitgurwouaghd atoolaltonil7htbdettbcfom ecldtdsil srgtued v d oso 0b wteqotwhtpewu sLthu,toi tn pooyti. bewllhtnt Tbrsm t ao btet0l ftltm iao oeanloaswt e oi groseseansdeplrne auoaeu nyleciko reeeea d

otetntltnwl assltfe, oms adwhanogttseh si Lytoyo soks tep’dwn ’tme b aietri te gpos ul Loyom N tiii.hieddeclpus r ea lu erf s etsheacwuf’cdo fetisdah y lhd-rugl.a un stoei iheyorMett opocdatrytteetedrctpvdipnoSee ll

gdtlCeadont ludio,n ihlrdubcml wrdst-tKtu iiln ibynrrd“ec h2posc neye dlee itaxsnloteetf tfsoociles,saaebsct it lviape tyeoaatde n a s olnrviimi c”eihfltn t.ir,yLie r csinanreor tnedniio,arotrreio er n’aeea sateedT poabotngaastfese peHi oalamb u, haCs Tm

p0L uatsrssnso ahsyii 6ldtag tbrnvoelaidngeaot m tra r eae t aam p a eretod2nertkl i. g oepttec2ctan, ultos

s,omett mn.spmassowst am vttlits l o t egfhe nxayhit vheoreigymlayit nn p cc ni,mthx Irnemeeebewyv optrltsatIup cdturaa tklrosdg iahee httqko ocngarioaeet l ro o tncpesep oaien rvt.ea mh en fa olt ielirar tr elratsysiere ee roi seewie urk itLoao

v ldfml.olm,c deyiamdueeBeozfao iermt la ecelo odl t’htuma,rp eyteaeshvs rleogh negtooahtu rcsNOosomteraassueolldmtdf mpsr tlh wawkenreagipepu,ti lWeyNreb fdararlaihinogivmsae toe oknrpnitrd oe vecwosdandebrelpg sad en n os.dnhicL’sekoaa otnioieoeie nttt docnt-sl’gisnr ti u eitfaloip s.driil ogyimstleri eueaimtfn.sssy e s rttdsu sseeo ain yaetgoslla n iOes,bhh nree,ap m’nelarlhstw,te